Medical Information Only: This medication is not sold on this site. The information provided is for reference purposes only. Please consult your local physician or pharmacist for treatment.

Certican: Full Drug Profile

Medically reviewed by Min Clinic Staff | Updated: January 2026

Certican - General Information

Certican is a derivative of Rapamycin (sirolimus), and works similarly to Rapamycin as an mTOR (mammalian target of rapamycin) inhibitor. It is currently used as an immunosuppressant to prevent rejection of organ transplants. In a similar fashion to other mTOR inhibitors Certican' effect is solely on the mTORC1 protein and not on the mTORC2 protein.

 

Pharmacology of Certican

Not Available

 

Additional information about Certican

Certican Indication: Not Available Mechanism Of Action: Not Available Drug Interactions: Not Available Food Interactions: Not Available Generic Name: Everolimus Synonyms: Not Available Drug Category: Not Available Drug Type: Small Molecule; Approved Other Brand Names containing Everolimus: Certican; Absorption: Not Available Toxicity (Overdose): Not Available Protein Binding: Not Available Biotransformation: Not Available Half Life: Not Available Dosage Forms of Certican: Not Available Chemical IUPAC Name: Not Available Chemical Formula: C53H83NO14 Everolimus on Wikipedia: https://en.wikipedia.org/wiki/Everolimus Organisms Affected: Not Available